Currently, Chemed has a gross margin of 33.6%, an operating margin of 13.9%, an EBITDA margin of 17.1%, and a net margin of 10.6%. The largest positive change was in gross margin, up 0.6 percentage points. The largest negative change was in net margin, down 0.4 percentage points.
Chemed's margins averaged 34.23% gross, 14.46% operating, 18.01% EBITDA, and 11.61% net during the last 3 years. All four current margins are lower than their three-year averages.
From the same period last year, gross margin expanded by 0.6 percentage points, while EBITDA margin contracted by 0.1 percentage points and net margin by 0.4 percentage points.
Over the last 3 years, Chemed's gross margin averaged 34.23%. The current gross margin of 33.6% is 0.6 percentage points below its three-year average. During this period, gross margin reached a high of 36% in Jun 2024 and a low of 32.5% in Dec 2025.
The average operating margin for Chemed was 14.46% over the last 3 years. As of the latest period, the current operating margin for Chemed is 13.9%, 0.6 percentage points below its three-year average. The operating margin for Chemed moved between 12.9% in Mar 2026 and 15.6% in Mar 2025.
The average EBITDA margin for Chemed was 18.01% over the last 3 years. Chemed's current EBITDA margin is 17.1% and is 0.9 percentage points below its three-year average. The EBITDA margin for Chemed moved between 16.4% in Mar 2026 and 19.3% in Sep 2024.
Across the last 3 years, Chemed had an average net margin of 11.61%. The latest net margin for Chemed is 10.6%, 1 percentage points below its three-year average. Looking back over the last 3 years, Chemed's net margin reached 12.9% at its highest point in Jun 2024 and 10.2% at its lowest in Mar 2026.
Chemed's gross margin of 33.6% is above the industry average but below the Healthcare sector average. Compared to its Healthcare sector average of 68.3%, Chemed's gross margin is 51% lower.
For the period ending Sep 30, 2026, CHE recorded a gross margin of 33.6%.
The current operating margin for CHE is 13.9% as of Sep 30, 2026.
For the period ending Sep 30, 2026, CHE recorded an EBITDA margin of 17.1%.
As of Sep 30, 2026, CHE has a net margin of 10.6%.
Across the last 3 years, CHE averaged 34.2% gross, 14.5% operating, 18.0% EBITDA, and 11.6% net.
Over this 5-year history, CHE peaked at 36.9% gross in Jun 2022, 17.4% operating in Jun 2022, 19.8% EBITDA in Jun 2022, and 12.9% net in Jun 2024.
Chemed's lowest recorded margins during the past 5 years were 32.5% gross in Dec 2025, 12.9% operating in Mar 2026, 16.4% EBITDA in Mar 2026, and 10.2% net in Mar 2026.